These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
348 related items for PubMed ID: 33915090
1. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis. Ovadia C, Sajous J, Seed PT, Patel K, Williamson NJ, Attilakos G, Azzaroli F, Bacq Y, Batsry L, Broom K, Brun-Furrer R, Bull L, Chambers J, Cui Y, Ding M, Dixon PH, Estiú MC, Gardiner FW, Geenes V, Grymowicz M, Günaydin B, Hague WM, Haslinger C, Hu Y, Indraccolo U, Juusela A, Kane SC, Kebapcilar A, Kebapcilar L, Kohari K, Kondrackienė J, Koster MPH, Lee RH, Liu X, Locatelli A, Macias RIR, Madazli R, Majewska A, Maksym K, Marathe JA, Morton A, Oudijk MA, Öztekin D, Peek MJ, Shennan AH, Tribe RM, Tripodi V, Türk Özterlemez N, Vasavan T, Wong LFA, Yinon Y, Zhang Q, Zloto K, Marschall HU, Thornton J, Chappell LC, Williamson C. Lancet Gastroenterol Hepatol; 2021 Jul; 6(7):547-558. PubMed ID: 33915090 [Abstract] [Full Text] [Related]
2. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Ovadia C, Seed PT, Sklavounos A, Geenes V, Di Ilio C, Chambers J, Kohari K, Bacq Y, Bozkurt N, Brun-Furrer R, Bull L, Estiú MC, Grymowicz M, Gunaydin B, Hague WM, Haslinger C, Hu Y, Kawakita T, Kebapcilar AG, Kebapcilar L, Kondrackienė J, Koster MPH, Kowalska-Kańka A, Kupčinskas L, Lee RH, Locatelli A, Macias RIR, Marschall HU, Oudijk MA, Raz Y, Rimon E, Shan D, Shao Y, Tribe R, Tripodi V, Yayla Abide C, Yenidede I, Thornton JG, Chappell LC, Williamson C. Lancet; 2019 Mar 02; 393(10174):899-909. PubMed ID: 30773280 [Abstract] [Full Text] [Related]
3. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial. Chappell LC, Bell JL, Smith A, Linsell L, Juszczak E, Dixon PH, Chambers J, Hunter R, Dorling J, Williamson C, Thornton JG, PITCHES study group. Lancet; 2019 Sep 07; 394(10201):849-860. PubMed ID: 31378395 [Abstract] [Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P. Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557 [Abstract] [Full Text] [Related]
5. Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES). Chappell LC, Chambers J, Dixon PH, Dorling J, Hunter R, Bell JL, Bowler U, Hardy P, Juszczak E, Linsell L, Rounding C, Smith A, Williamson C, Thornton JG. Trials; 2018 Nov 27; 19(1):657. PubMed ID: 30482254 [Abstract] [Full Text] [Related]
6. Ursodeoxycholic acid improves pregnancy outcome in patients with intrahepatic cholestasis during pregnancy: A protocol for systematic review and meta-analysis. Wang Y, Peng X, Zhang Y, Yang Q, Xiao Y, Chen Y. Medicine (Baltimore); 2021 Jan 29; 100(4):e23627. PubMed ID: 33530164 [Abstract] [Full Text] [Related]
7. Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy. Kawakita T, Parikh LI, Ramsey PS, Huang CC, Zeymo A, Fernandez M, Smith S, Iqbal SN. Am J Obstet Gynecol; 2015 Oct 29; 213(4):570.e1-8. PubMed ID: 26071912 [Abstract] [Full Text] [Related]
8. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study). Kong X, Kong Y, Zhang F, Wang T, Yan J. Medicine (Baltimore); 2016 Oct 29; 95(40):e4949. PubMed ID: 27749550 [Abstract] [Full Text] [Related]
10. Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial. Chappell LC, Gurung V, Seed PT, Chambers J, Williamson C, Thornton JG, PITCH Study Consortium. BMJ; 2012 Jun 13; 344():e3799. PubMed ID: 22695903 [Abstract] [Full Text] [Related]
11. Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations. Vasavan T, Deepak S, Jayawardane IA, Lucchini M, Martin C, Geenes V, Yang J, Lövgren-Sandblom A, Seed PT, Chambers J, Stone S, Kurlak L, Dixon PH, Marschall HU, Gorelik J, Chappell L, Loughna P, Thornton J, Pipkin FB, Hayes-Gill B, Fifer WP, Williamson C. J Hepatol; 2021 May 13; 74(5):1087-1096. PubMed ID: 33276032 [Abstract] [Full Text] [Related]
12. Ursodeoxycholic acid in the treatment of pregnancy cholestasis: a data-set available for Meta-analyses. Indraccolo U, Corleto CC, Milazzo GN, Bonito M, De Angelis C, Di Iorio R. J Matern Fetal Neonatal Med; 2022 Dec 13; 35(25):7968-7971. PubMed ID: 34134582 [Abstract] [Full Text] [Related]
13. Chappell LC, Bell JL, Smith A, Rounding C, Bowler U, Linsell L, Juszczak E, Tohill S, Redford A, Dixon PH, Chambers J, Hunter R, Dorling J, Williamson C, Thornton JG. ; 2020 12 13. PubMed ID: 33284566 [Abstract] [Full Text] [Related]
14. Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study. Manna LB, Ovadia C, Lövgren-Sandblom A, Chambers J, Begum S, Seed P, Walker I, Chappell LC, Marschall HU, Williamson C. BJOG; 2019 Dec 13; 126(13):1633-1640. PubMed ID: 31483939 [Abstract] [Full Text] [Related]
15. Is ursodeoxycholic acid effective for intrahepatic cholestasis of pregnancy? Sepúlveda Marín S, Contreras Maragaño V, Vera C. Medwave; 2016 Jan 08; 16 Suppl 1():e6361. PubMed ID: 26817509 [Abstract] [Full Text] [Related]
16. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis. Bacq Y, Sentilhes L, Reyes HB, Glantz A, Kondrackiene J, Binder T, Nicastri PL, Locatelli A, Floreani A, Hernandez I, Di Martino V. Gastroenterology; 2012 Dec 08; 143(6):1492-501. PubMed ID: 22892336 [Abstract] [Full Text] [Related]
17. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Kondrackiene J, Beuers U, Kupcinskas L. Gastroenterology; 2005 Sep 08; 129(3):894-901. PubMed ID: 16143129 [Abstract] [Full Text] [Related]
18. Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy [see comemnts]. Brites D, Rodrigues CM. J Hepatol; 1998 Nov 08; 29(5):743-51. PubMed ID: 9833912 [Abstract] [Full Text] [Related]
19. Society for Maternal-Fetal Medicine Consult Series #53: Intrahepatic cholestasis of pregnancy: Replaces Consult #13, April 2011. Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.orgSociety for Maternal-Fetal Medicine, 409 12 St. SW, Washington, DC 20024, USA. pubs@smfm.org., Lee RH, Mara Greenberg, Metz TD, Pettker CM. Am J Obstet Gynecol; 2021 Feb 08; 224(2):B2-B9. PubMed ID: 33197417 [Abstract] [Full Text] [Related]
20. Intrahepatic Cholestasis of Pregnancy: A Review of Diagnosis and Management. Wood AM, Livingston EG, Hughes BL, Kuller JA. Obstet Gynecol Surv; 2018 Feb 08; 73(2):103-109. PubMed ID: 29480924 [Abstract] [Full Text] [Related] Page: [Next] [New Search]